Retigabine: Anticonvulsant, Partial seizures, Clinical trial, Food and Drug Administration, European Medicines Agency, Potassium channel opener

Prices from
145.79

Featured

COMPARE ALL WEBSHOPS (2)

Description

Retigabine: Anticonvulsant, Partial seizures, Clinical trial, Food and Drug Administration, European Medicines Agency, Potassium channel opener

Description Description
Product Specifications Product specifications
Related results Related results
Next
Previous

Compare webshops (2)

Sort by:

€ 145.79

€ 145.79

Description (0)

Retigabine: Anticonvulsant, Partial seizures, Clinical trial, Food and Drug Administration, European Medicines Agency, Potassium channel opener

Product specifications

Brand OmniScriptum
EAN
  • 9786132769374

Betascript Publishers

Regulatory Requirement: Drug Discovery, Development, Food and Administration, European Medicines Agency, Japan...

€ 108.41
Compare 2 stores 2 stores

OmniScriptum

Eplivanserin: Insomnia, Sanofi- Aventis, Food and Drug Administration, European Medicines Agency, 5-...

€ 108.41
Compare 2 stores 2 stores

OmniScriptum

Approved Drug: Food and Drug Administration, Pharmaceutical drug, New Application, Clinical trial, discovery

€ 127.10
Compare 2 stores 2 stores

OmniScriptum

Certolizumab Pegol: Monoclonal antibodies, UCB (company), Rheumatoid arthritis, Tumor necrosis factor-alpha, Food...

€ 127.10
Compare 2 stores 2 stores
Featured Choice
€ 145.79
To Shop